Rise in prevalence of liver diseases is propelling the coagulation testing market value. Prolonged clotting may indicate liver disease or other deficiencies in specific clotting factors. Coagulation testing in individuals with liver disease is employed to determine unexplained bleeding.
Point-of-Care (POC) coagulation tests are gaining traction for the measurement of anticoagulant effects. These tests play an important role in detecting bleeding disorders and monitoring anticoagulant drugs.
Vendors operating in the coagulation testing market landscape are developing rapid POC solutions that can determine the coagulation status of patients taking any anticoagulant, including a direct oral anticoagulant.
Coagulation, also known as clotting, is a process in which the blood becomes viscous or thickens into a coherent mass. Coagulation of blood depends on the balance between factors promoting coagulation (procoagulants) and factors inhibiting coagulation (anticoagulants). Disturbances in this balance could lead to thrombosis and bleeding.
Fibrinogen, prothrombin, thromboplastin, calcium, and antihemophilic factor are various types of blood clotting factors. Prothrombin is a plasma protein present in normal plasma. It is an unstable protein that can be split easily into thrombin. Prothrombin is continually formed by the liver.
Thrombin is a protein enzyme with weak proteolytic capabilities. It acts on fibrinogen to form one molecule of fibrin monomer. Fibrin monomers polymerize with one another to form fibrin fibers. Thrombin stimulates platelets to release adenosine diphosphate (ADP).
Coagulation testing is employed to determine unexplained bleeding. It is also used in pre- and perioperative testing, monitoring of anticoagulant treatment, and research. Prothrombin Time (PT), Activated Partial Thromboplastin Clotting Time (APTT), Thrombin Time (TT), and Activated Clotting Time (ACT) are various test types.
PT measures the time it takes plasma to clot when exposed to tissue factor and reflects the extrinsic and common pathways of coagulation.
APTT measures the time it takes plasma to clot when exposed to substances that activate the contact factors. ACT measures the time it takes whole blood (rather than plasma) to clot when exposed to an activator of the intrinsic pathway.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Prothrombin formation decreases in liver diseases. Patients with liver disease frequently acquire a complex disorder of hemostasis secondary to their disease. Routine laboratory tests, such as PT and platelet count, are required in liver disease diagnosis.
Thus, increase in cases of liver diseases is augmenting the coagulation testing market size. Liver disease accounts for two million deaths annually and is responsible for 4% of all deaths (1 out of every 25 deaths worldwide), according to Global Burden of Liver Disease: 2023 Update.
In February 2024, F. Hoffmann-La Roche Ltd. launched three coagulation tests for three oral Factor Xa inhibitors namely apixaban, edoxaban, and rivaroxaban, in European countries accepting the CE mark.
Factor Xa inhibitors are prescribed for various cardiovascular indications such as non-valvular atrial fibrillation, coronary artery disease (CAD), peripheral arterial disease (PAD), and for the prevention and treatment of venous thromboembolism (VTE).
Surge in prevalence of CAD is expected to spur the coagulation testing market growth in the near future. CAD is the most common type of heart disease, leading to 375,476 deaths in 2021, according to the Centers for Disease Control and Prevention.
About 1 in 20 adults age 20 and older have CAD (about 5%). In 2021, about 2 in 10 deaths in adults less than 65 years old were from CAD.
R&D in POC coagulometers is propelling the coagulation testing market share in 2023. No POC diagnostic tool was available that could provide immediate insights into a patient's coagulation status when patients arrive with a bleed or require urgent surgery.
Healthcare professionals rely solely on clinical judgment to determine if a patient is adequately anticoagulated for reversal treatment. However, many players in the market are offering novel POC coagulometers that offer a real-time, comprehensive view of a patient's clotting status right in the emergency room.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
According to the latest coagulation testing market trends, North America held largest share in 2023. High prevalence of lifestyle disorders is fueling the market dynamics of the region. 4.5 million adults aged 18 and older are diagnosed liver disease in the U.S.
Rise in funding for advanced diagnostic technology is driving the coagulation testing market share in Europe. In November 2022, Enzyre, a Netherlands-based developer of ambulant diagnostic technology for blood coagulation testing, raised €12 Mn (US$ 11.9 Mn) in series A financing.
According to the company, the financing will be used to develop its diagnostic technology platform, EnzyPad, which will enable hemophilia patients to determine and monitor their coagulation status at home in real time.
Key players operating in the global coagulation testing market are introducing hand-held portable coagulation analyzers that deliver fast, reliable PT for POC monitoring and management of oral anticoagulation therapy.
F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, Sysmex Corporation, Universal Biosensors, Inc., HemoSonics, LLC, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Horiba, Ltd., Agappe Diagnostics Ltd., Medtronic, and Helena Laboratories, Inc. are key companies in the coagulation testing industry.
These companies have been profiled in the coagulation testing market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 3.4 Bn |
| Market Forecast (Value) in 2034 | US$ 6.5 Bn |
| Growth Rate (CAGR) | 6.0% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 3.4 Bn in 2023
It is projected to grow at a CAGR of 6.0% from 2024 to 2034
Rise in prevalence of cardiovascular diseases and R&D of biodegradable coronary stents
North America was the dominant region in 2023
F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthineers, Sysmex Corporation, Universal Biosensors, Inc., HemoSonics, LLC, Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Horiba, Ltd., Agappe Diagnostics Ltd., Medtronic, and Helena Laboratories, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Coagulation Testing Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Coagulation Testing Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Coagulation Testing Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Instruments
6.3.2. Consumables
6.4. Market Attractiveness Analysis, by Product Type
7. Global Coagulation Testing Market Analysis and Forecast, by Test Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Test Type, 2020-2034
7.3.1. Prothrombin Time (PT)
7.3.2. Activated Partial Thromboplastin Clotting Time (APTT)
7.3.3. Thrombin Time (TT)
7.3.4. Activated Clotting Time (ACT)
7.3.5. Others
7.4. Market Attractiveness Analysis, by Test Type
8. Global Coagulation Testing Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals and Clinics
8.3.2. Diagnostic Laboratories
8.3.3. Home Care Settings
8.3.4. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Coagulation Testing Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Coagulation Testing Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Product Type, 2020-2034
10.3.1. Instruments
10.3.2. Consumables
10.4. Market Value Forecast, by Test Type, 2020-2034
10.4.1. Prothrombin Time (PT)
10.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
10.4.3. Thrombin Time (TT)
10.4.4. Activated Clotting Time (ACT)
10.4.5. Others
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals and Clinics
10.5.2. Diagnostic Laboratories
10.5.3. Home Care Settings
10.5.4. Others
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Product Type
10.7.2. By Test Type
10.7.3. By End-user
10.7.4. By Country
11. Europe Coagulation Testing Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Product Type, 2020-2034
11.3.1. Instruments
11.3.2. Consumables
11.4. Market Value Forecast, by Test Type, 2020-2034
11.4.1. Prothrombin Time (PT)
11.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
11.4.3. Thrombin Time (TT)
11.4.4. Activated Clotting Time (ACT)
11.4.5. Others
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals and Clinics
11.5.2. Diagnostic Laboratories
11.5.3. Home Care Settings
11.5.4. Others
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Product Type
11.7.2. By Test Type
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific Coagulation Testing Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Product Type, 2020-2034
12.3.1. Instruments
12.3.2. Consumables
12.4. Market Value Forecast, by Test Type, 2020-2034
12.4.1. Prothrombin Time (PT)
12.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
12.4.3. Thrombin Time (TT)
12.4.4. Activated Clotting Time (ACT)
12.4.5. Others
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals and Clinics
12.5.2. Diagnostic Laboratories
12.5.3. Home Care Settings
12.5.4. Others
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Product Type
12.7.2. By Test Type
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America Coagulation Testing Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Product Type, 2020-2034
13.3.1. Instruments
13.3.2. Consumables
13.4. Market Value Forecast, by Test Type, 2020-2034
13.4.1. Prothrombin Time (PT)
13.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
13.4.3. Thrombin Time (TT)
13.4.4. Activated Clotting Time (ACT)
13.4.5. Others
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals and Clinics
13.5.2. Diagnostic Laboratories
13.5.3. Home Care Settings
13.5.4. Others
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Product Type
13.7.2. By Test Type
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa Coagulation Testing Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Product Type, 2020-2034
14.3.1. Instruments
14.3.2. Consumables
14.4. Market Value Forecast, by Test Type, 2020-2034
14.4.1. Prothrombin Time (PT)
14.4.2. Activated Partial Thromboplastin Clotting Time (APTT)
14.4.3. Thrombin Time (TT)
14.4.4. Activated Clotting Time (ACT)
14.4.5. Others
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals and Clinics
14.5.2. Diagnostic Laboratories
14.5.3. Home Care Settings
14.5.4. Others
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Product Type
14.7.2. By Test Type
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. F. Hoffmann-La Roche Ltd.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Abbott
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Siemens Healthineers
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Sysmex Corporation
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Universal Biosensors, Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. HemoSonics, LLC
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Thermo Fisher Scientific Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Randox Laboratories Ltd.
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Horiba, Ltd.
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Agappe Diagnostics Ltd.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
15.3.11. Medtronic
15.3.11.1. Company Overview
15.3.11.2. Product Portfolio
15.3.11.3. SWOT Analysis
15.3.11.4. Financial Overview
15.3.11.5. Strategic Overview
15.3.12. Helena Laboratories, Inc.
15.3.12.1. Company Overview
15.3.12.2. Product Portfolio
15.3.12.3. SWOT Analysis
15.3.12.4. Financial Overview
15.3.12.5. Strategic Overview
List of Tables
Table 01: Global Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 02: Global Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 03: Global Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global Coagulation Testing Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America Coagulation Testing Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 07: North America Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 08: North America Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe Coagulation Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 11: Europe Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 12: Europe Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 15: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 16: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 19: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 20: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, by Product Type, 2020-2034
Table 23: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, by Test Type, 2020-2034
Table 24: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global Coagulation Testing Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global Coagulation Testing Market Revenue (US$ Mn), by Product Type, 2023
Figure 03: Global Coagulation Testing Market Value Share, by Product Type, 2023
Figure 04: Global Coagulation Testing Market Revenue (US$ Mn), by Test Type, 2023
Figure 05: Global Coagulation Testing Market Value Share, by Test Type, 2023
Figure 06: Global Coagulation Testing Market Revenue (US$ Mn), by End-user, 2023
Figure 07: Global Coagulation Testing Market Value Share, by End-user, 2023
Figure 08: Global Coagulation Testing Market Value Share, by Region, 2023
Figure 09: Global Coagulation Testing Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 11: Global Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 13: Global Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 14: Global Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global Coagulation Testing Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America Coagulation Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America Coagulation Testing Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America Coagulation Testing Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 22: North America Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 23: North America Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 26: North America Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe Coagulation Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe Coagulation Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe Coagulation Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 31: Europe Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 32: Europe Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 35: Europe Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific Coagulation Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 40: Asia Pacific Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 41: Asia Pacific Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 44: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America Coagulation Testing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America Coagulation Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America Coagulation Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 49: Latin America Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 50: Latin America Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 53: Latin America Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Product Type, 2023 and 2034
Figure 58: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Test Type, 2023 and 2034
Figure 59: Middle East & Africa Coagulation Testing Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Test Type, 2024-2034
Figure 62: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Coagulation Testing Market
*86 figures and 60 tables includes